发明名称 |
Compositions for Treatment of Attention Deficit Hyperactivity Disorder |
摘要 |
Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms that deliver a therapeutic amount of active drug in a delayed and controlled release formulation. The dosage form can be administered at night and drug release is delayed for from 5 to 8 hours or longer, followed by a prolonged release. |
申请公布号 |
US2015366816(A1) |
申请公布日期 |
2015.12.24 |
申请号 |
US201514841428 |
申请日期 |
2015.08.31 |
申请人 |
Ironshore Pharmaceuticals & Development, Inc. |
发明人 |
Lickrish David;Zhang Feng |
分类号 |
A61K9/50;A61K31/137 |
主分类号 |
A61K9/50 |
代理机构 |
|
代理人 |
|
主权项 |
1. A solid, oral pharmaceutical composition comprising a plurality of particles, each comprising:
a core comprising dextroamphetamine or a pharmaceutical salt thereof and at least one pharmaceutically acceptable excipient; a extended release layer enclosing the core; and a delayed release layer enclosing the extended release layer,wherein the formulation provides at least an 8 hour lag period during which the formulation releases no more than 10% of the total dextroamphetamine or a pharmaceutical salt thereof followed by an extended release period of 10-12 hours when the composition is placed in 700 ml aqueous solution of 0.1N HCl pH 1.1, for up to 2 hours followed by hours 2-6 in sodium phosphate buffer at pH 6.0; followed by hours 6-20 in sodium phosphate buffer, pH 7.2 at 37° C.±0.0.5° C., measured by the USP Apparatus I. |
地址 |
Camana Bay KY |